InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,427.13
(
-2.31%
)
US TECH 100
18,600.00
(
-3.25%
)
Dow Jones
39,853.87
(
-1.25%
)
Brent Oil
80.31
(
-0.53%
)
Bitcoin
64,239.61
(
-1.73%
)
Post# of 708088
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Doktornolittle

Send PM Follow Ignore
Followers 31
Posts 2649
Boards Moderated 0
Alias Born 10/28/2013

Doktornolittle

Re: None

Thursday, 06/23/2016 9:47:29 PM

Thursday, June 23, 2016 9:47:29 PM

Post# of 708088
Merck has Avelumab that binds on the PD-L1 (Tumor) side. I don't know much about it.

Merck, however, seems to be in bad financial shape just like Astra Zeneca and Roche.

So what about GSK and BMY?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM

VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM

North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM

Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM

Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM

Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!